Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online:2474
  • Home
  • Print this page
  • Email this page


 
 Table of Contents  
LETTER TO THE EDITOR
Year : 2020  |  Volume : 34  |  Issue : 2  |  Page : 142

Headache in COVID-19: An observation


1 RVT Medical Academic Center, Bangkok, Thailand
2 Visiting University Professor, Department of Community Medicine, Dr. DY Patil University, Pune, Maharashtra, India; Department of Tropical Medicine, Hainan Medical University, Haikou, China

Date of Web Publication06-Aug-2020

Correspondence Address:
Dr. Won Sriwijitalai
RVT Medical Center, Bangkok
Thailand
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijpn.ijpn_37_20

Rights and Permissions

How to cite this article:
Sriwijitalai W, Wiwanitkit V. Headache in COVID-19: An observation. Indian J Pain 2020;34:142

How to cite this URL:
Sriwijitalai W, Wiwanitkit V. Headache in COVID-19: An observation. Indian J Pain [serial online] 2020 [cited 2020 Sep 30];34:142. Available from: http://www.indianjpain.org/text.asp?2020/34/2/142/291543



Sir,

Headache is an important clinical complaint. In several infectious diseases, headache might be a common clinical presentation. COVID-19[1] is the new emerging viral infection where patients commonly present with fever and dry cough. However, headache could be a clinical complaint in a subset of patients.

The available medical literature on clinical presentation of 46 patients[2],[3] showed that headache was observed in three cases (rate = 6.52, 95% confidence interval = 2.18%–19.48%). In our setting in Thailand, where the disease has already emerged,[3] of 42 cases of COVID in Thailand, three have headache (rate = 7.14, 95% confidence interval = 2.40%–21.25%). Regarding the nature of headache, it is usually bilateral generalized pounding headache. However, there are no available data on the duration and frequency of headache. No major precipitating or relieving factor is described in these patients. There is no effect of noise or light or no significant alteration of vision or sleep. Since there is no significant neurological deficit, there is no need for additional neuroimaging in such patients.

The rate in Thai patients is similar to that in Chinese patients. Based on this information, headache might be a possible but not common clinical presentation in COVID-19 infection.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflict of interest.



 
  References Top

1.
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020;382:727-33.  Back to cited text no. 1
    
2.
Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster. Lancet 2020;395:514-23.  Back to cited text no. 2
    
3.
Yasri S, Wiwanitkit V. Editorial: Wuhan coronavirus outbreak and imported case. Adv Trop Med Pub Health Int 2020;10:1-2.  Back to cited text no. 3
    




 

Top
 
 
  Search
 
Similar in PUBMED
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

 
  In this article
References

 Article Access Statistics
    Viewed188    
    Printed4    
    Emailed0    
    PDF Downloaded21    
    Comments [Add]    

Recommend this journal